Effect of lipid environment on amyloid fibril formation of human serum amyloid A

被引:21
|
作者
Tanaka, Masafumi [1 ]
Nishimura, Ayaka [1 ]
Takeshita, Haruka [1 ]
Takase, Hiroka [1 ]
Yamada, Toshiyuki [2 ]
Mukai, Takahiro [1 ]
机构
[1] Kobe Pharmaceut Univ, Dept Biophys Chem, Kobe, Hyogo 6588558, Japan
[2] Jichi Med Univ, Dept Clin & Lab Med, Shimotsuke, Tochigi 3290498, Japan
关键词
Serum amyloid A; Lipid binding; High-density lipoprotein; Apolipoprotein; APOLIPOPROTEIN-A-I; FRAGMENT PEPTIDES; BETA-PROTEIN; MEMBRANES; BINDING; INFLAMMATION; AGGREGATION; CHOLESTEROL; DENSITY; REGIONS;
D O I
10.1016/j.chemphyslip.2016.11.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human serum amyloid A (SAA) is a precursor protein of AA amyloidosis and a component of high-density lipoproteins (HDLs), thus it is essential to investigate the amyloid fibril formation of SAA under a lipid environment. We used synthetic fragment peptides corresponding to the N-terminal (residues 1-27) and central (residues 43-63) regions of the SAA molecule, which are known to have amyloidogenic properties. Measurements of tryptophan fluorescence in conjunction with circular dichroism showed that SAA (1-27) peptide binds to neutral and acidic lysophospholipids, whereas SAA (43-63) peptide binds only to acidic lysophospholipids. For both these SAA peptides, binding to lysophospholipids inhibited heparin-induced amyloid-like fibril formation by stabilizing the a-helical structure. However, acidic lysophospholipids implied a possibility to promote fibril formation of SAA (1-27) peptide by themselves. These results suggest that the amyloid fibril formation of SAA may be modulated by altering the lipid head group composition of HDLs during metabolism. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:6 / 12
页数:7
相关论文
共 50 条
  • [1] Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A
    Takase, Hiroka
    Tanaka, Masafumi
    Yamamoto, Aki
    Watanabe, Shiori
    Takahashi, Sanae
    Nadanaka, Satomi
    Kitagawa, Hiroshi
    Yamada, Toshiyuki
    Mukai, Takahiro
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (02): : 67 - 75
  • [2] Influences of amino-terminal modifications on amyloid fibril formation of human serum amyloid A
    Tanaka, Masafumi
    Takarada, Toru
    Nadanaka, Satomi
    Kojima, Risa
    Hosoi, Kimiko
    Machiba, Yuki
    Kitagawa, Hiroshi
    Yamada, Toshiyuki
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 742
  • [3] Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A
    Tanaka, Masafumi
    Kawakami, Toru
    Okino, Nozomi
    Sasaki, Kaoru
    Nakanishi, Kiwako
    Takase, Hiroka
    Yamada, Toshiyuki
    Mukai, Takahiro
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, 639 : 9 - 15
  • [4] FIBRIL FORMATION FROM RECOMBINANT HUMAN SERUM AMYLOID-A
    YAMADA, T
    KLUVEBECKERMAN, B
    LIEPNIEKS, JJ
    BENSON, MD
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1226 (03): : 323 - 329
  • [5] Serum amyloid A, conformation, catabolism and cholesterol implications for amyloid A fibril formation
    Sipe, JD
    Schreiber, BM
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 29 - 30
  • [6] Effect of Cholesterol and Lipid Charge on Amyloid Fibril Formation on Model Lipid Membrane
    Drolle, Elizabeth
    Hane, Francis
    Faught, Erin
    Leonenko, Zoya
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 160 - 160
  • [7] Effect of Surfaces on Amyloid Fibril Formation
    Moores, Bradley
    Drolle, Elizabeth
    Attwood, Simon J.
    Simons, Janet
    Leonenko, Zoya
    PLOS ONE, 2011, 6 (10):
  • [8] AMYLOID FIBRIL FORMATION
    COLACO, CALS
    HARRINGTON, CR
    BIO-TECHNOLOGY, 1994, 12 (09): : 848 - 849
  • [9] Inhibition of amyloid fibril formation of human amylin
    Rijkers, DTS
    Höppener, JWM
    Posthuma, G
    Lips, CJM
    Liskamp, RMJ
    BIOPOLYMERS, 2003, 71 (03) : 324 - 324
  • [10] STRUCTURAL PREREQUISITES FOR SERUM AMYLOID-A FIBRIL FORMATION
    DEBEER, MC
    DEBEER, FC
    MCCUBBIN, WD
    KAY, CM
    KINDY, MS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (27) : 20606 - 20612